CSR Draft Report Proposes New Panel To Review Clinical Oncology Research
In Brief: NBCC Plans Meetings On Quality Of Care, Potential Environmental Causes Of Disease
Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says
In Congress: Gore, Democrats Rally For Anti-Tobacco Legislation
Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
